COMPOSE DE QUINAZOLINE

• 收藏
• 分享

专利权人:

ASTELLAS PHARMA INC.

发明人:

KURAMOTO, KAZUYUKI,AKAIWA, MICHINORI,ABE, TOMOAKI,ARAKI, TAKANOBU,YAMAKI, SUSUMU,KUNIKAWA, SHIGEKI,IMAIZUMI, TOMOYOSHI,NIGAWARA, TAKAHIRO,ARAKAWA, KEISUKE,SHIMADA, ITSURO,SHIMAZAKI, MASASHI,SATAKE, YO

申请号：

CA3052125

公开号：

CA3052125A1

申请日:

2018.02.01

申请国别(地区):

CA

年份:

2018

代理人:

摘要：

[Problem] To provide a compound that is useful as an active ingredient of a pharmaceutical composition for the treatment of lung cancer. [Solution] The present inventors examined compounds that are useful as an active ingredient of a pharmaceutical composition for the treatment of lung cancer and found that a quinazoline compound exhibits superior G12C-mutant-KRAS inhibiting activity and could be used as a lung-cancer treatment drug, thus arriving at the present invention. The quinazoline compound according to the present invention or a salt thereof could be used as a lung-cancer treatment drug.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/